Market Closed -
Nyse
16:00:02 2024-06-26 EDT
|
5-day change
|
1st Jan Change
|
174.8
USD
|
+1.48%
|
|
-0.69%
|
-30.50%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
5,735
|
6,354
|
10,734
|
8,449
|
9,709
|
6,777
|
-
|
-
|
Enterprise Value (EV)
1 |
5,735
|
6,354
|
10,734
|
8,287
|
9,567
|
6,488
|
6,379
|
6,198
|
P/E ratio
|
123
x
|
-398
x
|
2,052
x
|
-4,449
x
|
108
x
|
63.9
x
|
46.7
x
|
34.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
10.5
x
|
11.3
x
|
14.4
x
|
9.97
x
|
9.17
x
|
5.46
x
|
4.7
x
|
4.07
x
|
EV / Revenue
|
10.5
x
|
11.3
x
|
14.4
x
|
9.78
x
|
9.04
x
|
5.23
x
|
4.42
x
|
3.72
x
|
EV / EBITDA
|
103
x
|
410
x
|
209
x
|
214
x
|
74.4
x
|
37.6
x
|
27.4
x
|
20.7
x
|
EV / FCF
|
1,262
x
|
-110
x
|
-919
x
|
-111
x
|
116
x
|
55.7
x
|
40.2
x
|
33.9
x
|
FCF Yield
|
0.08%
|
-0.91%
|
-0.11%
|
-0.9%
|
0.86%
|
1.79%
|
2.49%
|
2.95%
|
Price to Book
|
11.8
x
|
9.93
x
|
11.3
x
|
8.49
x
|
8.25
x
|
5.36
x
|
4.58
x
|
3.62
x
|
Nbr of stocks (in thousands)
|
34,914
|
36,311
|
37,359
|
37,979
|
38,596
|
38,765
|
-
|
-
|
Reference price
2 |
164.3
|
175.0
|
287.3
|
222.5
|
251.5
|
174.8
|
174.8
|
174.8
|
Announcement Date
|
20-02-25
|
21-02-23
|
22-02-22
|
23-02-23
|
24-02-22
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
547.4
|
560.4
|
747.6
|
847.1
|
1,059
|
1,241
|
1,443
|
1,666
|
EBITDA
1 |
55.61
|
15.49
|
51.45
|
38.73
|
128.5
|
172.5
|
232.8
|
299.7
|
EBIT
1 |
47.51
|
2.595
|
35.04
|
14.41
|
101.3
|
139.7
|
191.1
|
260.2
|
Operating Margin
|
8.68%
|
0.46%
|
4.69%
|
1.7%
|
9.57%
|
11.26%
|
13.24%
|
15.62%
|
Earnings before Tax (EBT)
1 |
50.14
|
-
|
-10.5
|
3.892
|
79.65
|
138.6
|
187.5
|
256
|
Net income
1 |
48.46
|
-15.7
|
5.284
|
-2.002
|
90.95
|
107.2
|
149.9
|
204.6
|
Net margin
|
8.85%
|
-2.8%
|
0.71%
|
-0.24%
|
8.59%
|
8.64%
|
10.39%
|
12.28%
|
EPS
2 |
1.340
|
-0.4400
|
0.1400
|
-0.0500
|
2.320
|
2.735
|
3.745
|
5.031
|
Free Cash Flow
1 |
4.543
|
-58
|
-11.68
|
-74.96
|
82.12
|
116.4
|
158.6
|
183
|
FCF margin
|
0.83%
|
-10.35%
|
-1.56%
|
-8.85%
|
7.76%
|
9.38%
|
10.99%
|
10.99%
|
FCF Conversion (EBITDA)
|
8.17%
|
-
|
-
|
-
|
63.89%
|
67.49%
|
68.11%
|
61.07%
|
FCF Conversion (Net income)
|
9.38%
|
-
|
-
|
-
|
90.29%
|
108.59%
|
105.79%
|
89.45%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-02-25
|
21-02-23
|
22-02-22
|
23-02-23
|
24-02-22
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
204
|
203.9
|
208.3
|
213.7
|
221.2
|
241.4
|
261.5
|
270.9
|
284.7
|
278.7
|
297.6
|
321
|
343.1
|
325.6
|
347
|
EBITDA
1 |
8.241
|
3.465
|
5.79
|
14.04
|
13.65
|
16.96
|
26.98
|
40.15
|
44.45
|
26.82
|
36.55
|
52.21
|
59.39
|
43.67
|
49.79
|
EBIT
1 |
2.488
|
-2.261
|
1.646
|
7.814
|
7.213
|
10.39
|
20.27
|
33.22
|
37.41
|
19.3
|
27.29
|
43.52
|
50.61
|
34.97
|
41.83
|
Operating Margin
|
1.22%
|
-1.11%
|
0.79%
|
3.66%
|
3.26%
|
4.3%
|
7.75%
|
12.26%
|
13.14%
|
6.93%
|
9.17%
|
13.55%
|
14.75%
|
10.74%
|
12.05%
|
Earnings before Tax (EBT)
1 |
-40.95
|
-5.104
|
-1.167
|
3.035
|
7.128
|
8.652
|
19.54
|
13.3
|
38.16
|
14.63
|
26.81
|
43.02
|
50.77
|
35.82
|
42.03
|
Net income
1 |
-24.63
|
0.079
|
-3.687
|
-2.271
|
3.877
|
8.562
|
18.96
|
9.214
|
54.22
|
11
|
20.98
|
33.65
|
39.79
|
29.44
|
34.55
|
Net margin
|
-12.07%
|
0.04%
|
-1.77%
|
-1.06%
|
1.75%
|
3.55%
|
7.25%
|
3.4%
|
19.05%
|
3.95%
|
7.05%
|
10.48%
|
11.6%
|
9.04%
|
9.96%
|
EPS
2 |
-0.6600
|
-
|
-0.1000
|
-0.0600
|
0.1000
|
0.2200
|
0.4800
|
0.2300
|
1.380
|
0.2800
|
0.5373
|
0.8644
|
1.021
|
0.7433
|
0.8704
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
22-02-22
|
22-05-03
|
22-08-04
|
22-11-03
|
23-02-23
|
23-05-02
|
23-08-01
|
23-11-02
|
24-02-22
|
24-05-07
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
161
|
142
|
289
|
398
|
579
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
4.54
|
-58
|
-11.7
|
-75
|
82.1
|
116
|
159
|
183
|
ROE (net income / shareholders' equity)
|
7.84%
|
0.71%
|
3.3%
|
0.65%
|
7.52%
|
8.59%
|
10.1%
|
12%
|
ROA (Net income/ Total Assets)
|
6.03%
|
0.54%
|
2.55%
|
0.49%
|
5.59%
|
6.79%
|
8.03%
|
9.36%
|
Assets
1 |
804
|
-2,929
|
207.5
|
-410.2
|
1,627
|
1,580
|
1,868
|
2,186
|
Book Value Per Share
2 |
13.90
|
17.60
|
25.40
|
26.20
|
30.50
|
32.60
|
38.20
|
48.30
|
Cash Flow per Share
2 |
0.7300
|
-0.9300
|
-
|
-1.470
|
2.480
|
3.260
|
4.290
|
5.750
|
Capex
1 |
22.1
|
24.8
|
21.2
|
19.3
|
15.2
|
17.5
|
17.7
|
13.1
|
Capex / Sales
|
4.04%
|
4.42%
|
2.83%
|
2.28%
|
1.44%
|
1.41%
|
1.23%
|
0.78%
|
Announcement Date
|
20-02-25
|
21-02-23
|
22-02-22
|
23-02-23
|
24-02-22
|
-
|
-
|
-
|
Last Close Price
174.8
USD Average target price
270.8
USD Spread / Average Target +54.92% Consensus |
1st Jan change
|
Capi.
|
---|
| -30.50% | 6.78B | | +75.69% | 12.57B | | +12.50% | 7B | | +9.11% | 5.2B | | -19.22% | 4.67B | | +19.81% | 4.26B | | -21.04% | 3.84B | | -28.39% | 2.7B | | -2.35% | 1.98B | | +21.63% | 1.95B |
Medical Equipment
|